Traws Pharma, Inc. announced on June 22, 2026, its intention to resubmit an updated data package to the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for the planned testing of tivoxavir marboxil. Traws Pharma, Inc. is a pharmaceutical company focused on developing and testing clinical trial testing of drug candidates.
